West African pharmaceutical sovereignty takes center stage in Lomé

Lomé, August 12, 2026 — The West African medical and academic community has reached a critical crossroads: either continue relying on massive pharmaceutical imports or build homegrown health industries. This pivotal moment unfolded at the Agora Senghor in Lomé during the 21st edition of the West African Pharmaceutical Students Federation (FESPAO) Scientific and Cultural Conference, where the blueprint for a complete overhaul of regional health strategy was laid out.

The gathering, organized by FESPAO, saw emerging medical leaders move beyond mere budgetary requests. They are now demanding a fundamental shift in doctrine—moving away from the inherited model of mere distribution to embracing industrialization, genomic research, and the scientific validation of traditional knowledge.

Local production as a national security imperative

The global pandemic and recent supply chain disruptions have served as wake-up calls for the continent. The heavy reliance on imported medicines is no longer just an economic anomaly; it represents a major national security vulnerability. This was the core argument presented during the summit.

Professor Gado Tchangbédji, Togo’s Minister Delegate for Higher Education and Research, outlined the new government-driven direction under President Faure Essozimna Gnassingbé: positioning innovation and local pharmaceutical production as the region’s shield against future pandemics. To achieve this, the state has committed to substantial support for scientific cooperation and applied research.

Genomic epidemiology and indigenous knowledge at the forefront

Local production alone isn’t sufficient if it merely replicates foreign patents. True sovereignty requires tailoring treatments to the continent’s unique characteristics. The Lomé conference emphasized an urgent scientific priority: developing therapies based on the genetic makeup of African populations, which have been largely overlooked in global clinical trials.

The push for scientific modernization is complemented by a cultural revival. Experts advocate for the industrial valorization of traditional pharmacopeia—not as informal practices, but through rigorous clinical trials to patent entirely new African-derived active molecules.

Redefining the pharmacist’s role

This industrial and scientific ambition faces a critical human capital challenge. The sector’s evolution demands a corresponding transformation in academic training. Professor Tchin Darré, Minister Delegate for Health and Dean of the Faculty of Health Sciences at the University of Lomé, highlighted the cornerstone of this revolution: curriculum reform. Tomorrow’s West African pharmacist must transcend the role of a simple dispenser behind a counter. They are poised to become cutting-edge researchers, key players in manufacturing industries, and specialists in validating indigenous knowledge.

As discussions continue in Lomé, the 21st edition of these Assises has set a clear objective: transform these academic debates into binding public policy proposals. The goal is to ensure universal healthcare access in West Africa no longer hinges on factories located thousands of kilometers away from patients.

In essence, the stakes are life-and-death. Without a robust local pharmaceutical industry and research rooted in African realities, West Africa will remain dependent on foreign solutions. With future pandemics looming, this dependency could have tragic consequences. True health sovereignty will be determined by the states’ ability to translate these resolutions into concrete actions—ensuring every African patient has access to care designed, validated, and produced on their own continent.